Heart Failure

Alan S Maisel MDProfessor of Medicine, Director, CCU and HF Program, Department of Medicine and Cardiology, VA Medical Centre, University of California, San Diego, California, USAGerasimos Filippatos MD FACC FCCP FESCDepartment of Cardiology, Heart Failure Unit, University of Athens, Greece

• Section 1: The Emergency DepartmentHow to Evaluate Dyspnea in the Emergency DepartmentHeart Failure Disposition: When to Admit, When to Observe, and When to Discharge HomeThe Treatment of Acute Heart Failure in the Emergency DepartmentManagement of Atrial Fibrillation in Patients with Heart Failure and Preserved andLow Ejection FractionsHow to Use Natriuretic Peptides in the Emergency DepartmentHow to Use New Biomarkers in the Emergency DepartmentThe Role of Ultrasound in the Management of Acute Heart FailureUse of Bioelectrical Impedance Vector Analysis in the Dyspneic PatientMechanical Ventilation in Acute Heart Failure: The Role of Noninvasive VentilationEmergency Department Observation Unit: Management of Congestive Heart FailureWhen to Employ Cardiac Magnetic Resonance Imaging and Cardiac Computed Tomography in the Evaluation of Heart FailureWhen to Discharge the Heart Failure Patient Section 2: Heart Failure in the HospitalHow to Use Natriuretic Peptides in the Inpatient Setting?Approaches to Diuretics in the HospitalVasodilators in Acute Heart FailureWhen and How to Use Inotropes?New Cardiovascular Disease Biomarkers in Hospital Medicine: Neutrophil Gelatinase-associated LipocalinPractical Approach to Hyponatremia in Heart FailureHeart Failure and Acute Coronary SyndromeThe ABCs of Isolated Venovenous Ultrafiltration in Fluid-overloaded Heart Failure PatientsWho Should Receive a Pulmonary Artery Catheter Section 3: Chronic Heart Failure in the Outpatient SettingOutpatient Follow-up—What Should We MonitorEchocardiography: Getting It RightA Practical Guide for Reducing Readmissions in Heart FailureInitiation of Angiotensin-converting Enzyme Inhibitors and Beta Blockers in Heart Failure: Putting Evidence into PracticeMineralocorticoid Receptor Antagonists in Patients with Heart Failure and a Reduced Left Ventricular Ejection Fraction: How to Do It RightAtrial Fibrillation Done RightVentricular Tachycardia Done RightIssues in AnticoagulationManagement of the Patient with Heart Failure with Preserved Ejection FractionImplantable Cardioverter-defibrillator and Cardiac Resynchronization Therapy inHeart Failure Patients: How to Choose the Right Device for the Right PatientsClinical Decision-making in the Outpatient Setting: The Use of Galectin-3Guiding Heart Failure Care with Natriuretic PeptidesST2: How to Really Do It RightUsing Cardiac Troponin to Assist in the Management of Patients with Congestive Heart Failure—A Practical GuideBiomarkers on the Horizon for Chronic Heart Failure Section 4: Special Issues in Heart FailureSex Differences in Heart Failure: Implications for Clinical PracticeChronic Heart Failure in Geriatric PatientsHow to Diagnose and Treat Anemia in Patients with Heart FailureDiabetes Management in Heart FailureHeart Failure in EuropeHeart Failure in Southeast AsiaHeart Failure in IndiaHeart Failure in India: Clinical PerspectiveHeart Failure in ChinaHeart Failure from the US Veterans Health Administration Perspective: A Patient-centered Approach to CareHeart Failure in the Nursing Home SettingHeart Failure from the Nursing PerspectiveDeveloping Heart Failure Service in a Developing Nation: Borneo Malaysia Perspective Section 5: Advanced Heart FailureApproach to the End-stage Heart Failure PatientLeft Ventricular Assist Device Versus Transplantation: How to DecideApproach to Left Ventricular Assist Devices and Follow-up in Advanced Congestive Heart FailureHow to Approach Palliative and End-of-life CarePercutaneous Mechanical Circulatory Support in Cardiogenic Shock Section 6: Cardiomyopathies: Practical Recommendations to Diagnosis and ManagementNew Onset Cardiomyopathy: Biopsy or MRI and Other Imaging ModalitiesHypertrophic CardiomyopathyTakotsubo CardiomyopathyMyocarditisWhen is Genetic Testing Necessary?AIDS-induced Cardiac Abnormalities and Heart FailureProhormone Levels in Heart Failure